ADULT LIVER PROGENITOR CELLS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE
展开▼
机译:用于治疗非酒精性脂肪肝疾病的成人肝祖细胞
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of a composition comprising adult human liver- derived progenitor cells, such as heterologous human adult liver-derived progenitor cells (HALPC), for the treatment of a patient having non-alcoholic fatty liver disease (NAFLD), such as non-alcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH), or wherein the patient is at risk of developing NASH. The treatment comprises a step of administering to said patient an amount of said composition which comprises a dose of 0.25 to 2.5 million said progenitor cells per kg body weight; wherein the composition is substantially free of an effective amount of an anticoagulant, and wherein the patient does not receive any co-treatment with an anticoagulant.
展开▼